从tasc分级演变展望pad治疗前景.pptVIP

解放军总医院血管外科 贾鑫、郭伟、刘小平、尹太、熊江、马晓辉等 TASC Trans-Atlantic Inter-Society Consensus committee TASC 2000, included Working Group members from 14 societies composed of vascular surgery, interventional radiology, angiology, and cardiology, as well as experts in health economy and epidemiology. TASC 2007 included Working Group members from 16 societies, not only from North America and Europe, but also from Japan, Australia, and South Africa. Further, podiatry experts and experts of evidence-based medicine were included. TASC I TASC II A Endovascular treatment of choice B Endovascular treatment is recommended C Surgical treatment is recommended D Surgical treatment of choice I Single Stenosis or occlusion 5cm TASC演变： D C （腹股沟上） B/C A （腹股沟下） 腹股沟下病变演变明显－－－效果？ 问题：看病不看人 TASC分级是PAD治疗的纲领－－绝对性 TASC分级是不断演变的－－相对性（基于病变） 腔内治疗是PAD治疗的发展方向 We are seeing an increasing population requiring prevention and also treatment and more focus on endovascular treatment. The TASC classification of lesions has been kept as such, but modified to reflect increased evidence for endovascular treatment of more extensive lesions. --------Lars Norgren, MD 谢 谢 * | MDT Confidential 从TASC分级演变展望PAD治疗前景 A Collaboration of the American College of Cardiology, the American Heart Association, the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society for Vascular Medicine and Biology, and the PAD Coalition. Class III Risk ≥ BenefitNo additional studies needed Procedure/Treatment should NOT be performed/administered SINCE IT IS NOT HELPFUL AND MAY BE HARMFUL Class IIb Benefit ≥ RiskAdditional studies with broad objectives needed; Additional registry data would be helpful Procedure/Treatment MAY BE CONSIDERED Class IIa Benefit RiskAdditional studies with focused objectives needed IT IS REASONABLE to perform procedu